✦ LIBER ✦

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker

✍ Scribed by Glenda G. Callender; Michael E. Egger; Alison L. Burton; Charles R. Scoggins; Merrick I. Ross; Arnold J. Stromberg; Lee Hagendoorn; C.G. Robert Martin II; Kelly M. McMasters

Book ID: 116217343
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 468 KB
Volume: 202
Category: Article
ISSN: 0002-9610
DOI: 10.1016/j.amjsurg.2011.06.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic implications of anatomic loca

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker

✍ Glenda G. Callender; Michael E. Egger; Alison L. Burton; Charles R. Scoggins; Me 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Primary cutaneous melanoma. Prognostic c

Primary cutaneous melanoma. Prognostic classification of anatomic location

✍ Claus Garbe; Petra Büttner; Jochen Bertz; Günter Burg; Barbara D'Hoedt; Hubert D 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Expression of melan-a/MART-1 antigen as

Expression of melan-a/MART-1 antigen as a prognostic factor in primary cutaneous melanoma

✍ Magali Berset; Jean-Philippe Cerottini; David Guggisberg; Pedro Romero; François 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 388 KB 👁 2 views

Randomised trial of interferon α-2a as a

Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases

✍ Jean Jacques Grob; Brigitte Dreno; Pauline de la Salmoniere; Michele Delaunay; D 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 89 KB

Primary Melanoma Location on the Scalp i

Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas

✍ Huismans, Anna M.; Haydu, Lauren E.; Shannon, Kerwin F.; Quinn, Michael J.; Saw, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 254 KB

Final results of the EORTC 18871/DKG 80-

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis

✍ U.R. Kleeberg; S. Suciu; E.B. Bröcker; D.J. Ruiter; C. Chartier; D. Liénard; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 292 KB